With the technological advancements of high‐quality lightings and high‐end displays, white light‐emitting‐diodes (w‐LEDs) are quickly developing towards high energy density excitation, high output power and high device stability, which requires outstanding thermal properties of the phosphor color converters. In this connection, all‐inorganic luminescent glass ceramic (GC), exhibiting excellent physical/chemical stability to address the serious aging and yellowing issues of conventional phosphor/silicone composite, receives great attention recently and is regarded as a new generation color converter with longevity. Herein, a thorough survey of the research progress of this kind of material is made, with focus put on the design principle, microstructure‐property relationship, packaging technology and the burgeoning application direction. Some challenging issues are discussed and potential directions are suggested for further developing the phosphor‐glass composite fulfilling various requirements in practical application. This Review can promote rapid progress of long‐lifetime high‐power w‐LEDs.
An ultrafast microwave annealing process has been developed to reduce the defect density in vertically aligned carbon nanotubes (CNTs). Raman and thermogravimetric analyses have shown a distinct defect reduction in the CNTs annealed in microwave for 3 min. Fibers spun from the as-annealed CNTs, in comparison with those from the pristine CNTs, show increases of approximately 35% and approximately 65%, respectively, in tensile strength ( approximately 0.8 GPa) and modulus (approximately 90 GPa) during tensile testing; an approximately 20% improvement in electrical conductivity (approximately 80000 S m(-1)) was also reported. The mechanism of the microwave response of CNTs was discussed.
BackgroundMalignant peripheral nerve sheath tumor (MPNST) is a kind of rare neurogenic tumor. If associated with neurofibromatosis type 1, MPNST usually has a higher mortality. The aim of the article is to assess the imaging characteristics of MPNST and compare them with those of benign peripheral nerve sheath tumor (BPNST) to characterize this tumor.MethodsClinical and imaging data of six cases with MPNST and 28 cases with BPNST in our institution since 2011 were retrospectively reviewed. Thirty-three patients have available MR imaging data, and two patients of MPNST also accepted CT scan. One patient accepted CT scan only. Location, size, shape, signal or density, boundary, bone destruction, relation to adjacent nerve, contrast-enhanced features as well as some other signs were assessed and compared with statistical software. Student’s t test was used for comparison of continuous variables. Fisher’s exact test was used for analysis of nominal variable. A P value ≤0.05 was considered to be statistically significant.ResultsDifferences existed between two groups in tumor size ((7.2 ± 3.3)cm in MPNST vs. (3.8 ± 1.4)cm in BPNST), unclear margin (4/6 in MPNST vs. 1/28 in BPNST), eccentricity to the nerve (1/6 in MPNST vs. 21/28 in BPNST), intratumoral lobulation (4/6 in MPNST vs. 2/28 in BPNST), peritumoral edema (3/6 in MPNST vs. 0 in BPNST), and peripheral enhancement (4/6 in MPNST (three of five MR, one CT) vs. 4/28 in BPNST). Bone destruction was observed in one MPNST.ConclusionsMR imaging is a valuable, non-invasive modality for the diagnosis of MPNST. Peripheral enhancement with non-cystic appearance or remarkable heterogeneous enhancement may be useful for differential diagnosis. Other imaging features such as large size (over 5 cm in diameter), ill-defined margin, intratumoral lobulation, peritumoral edema, and adjacent bone destruction are also supportive of MPNST.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.